1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. Firefly Neuroscience Acquires Evoke Neuroscience

M&A Deal Summary

Firefly Neuroscience Acquires Evoke Neuroscience

On May 5, 2025, Firefly Neuroscience acquired medical products company Evoke Neuroscience

Acquisition Highlights
  • This is Firefly Neuroscience’s 1st transaction in the Medical Products sector.
  • This is Firefly Neuroscience’s 1st transaction in the United States.
  • This is Firefly Neuroscience’s 1st transaction in New York.

M&A Deal Summary
Date 2025-05-05
Target Evoke Neuroscience
Sector Medical Products
Buyer(s) Firefly Neuroscience
Deal Type Add-on Acquisition

Target

Evoke Neuroscience

New York, New York, United States
Evoke Neuroscience is a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. Evoke Neuroscience is based in New York, New York.

Search 207,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Firefly Neuroscience

Buffalo, New York, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Firefly Neuroscience is an AI company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Firefly Neuroscience was founded in 2006 and is based in Buffalo, New York.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal